Bionano Genomics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	3.43	2.99	9.17	17.95	5.09	24.57
Short-Term Investments	10.98	16.28	0.3	48.82	108.1	226.04
Cash & Short-Term Investments	14.41	19.27	9.48	66.77	113.19	250.61
Cash Growth	-20.99%	103.37%	-85.81%	-41.01%	-54.84%	551.80%
Accounts Receivable	4.13	5.2	4.75	9.32	7.02	4.93
Inventory	5.31	5.45	11.12	22.89	29.76	12.39
Other Current Assets	15.13	15.47	14.14	41.14	7.33	4.48
Total Current Assets	38.98	45.39	39.49	140.12	157.3	272.41
Net Property, Plant & Equipment	20.15	21.16	24.32	32.48	28.96	37.46
Other Intangible Assets	3.01	4.35	9.71	33.97	41.14	56.16
Goodwill	-	-	-	-	77.29	0.75
Other Long-Term Assets	2.68	2.69	3.15	7.83	2.81	11.07
Total Assets	64.8	73.58	76.67	214.4	307.5	377.1
Accounts Payable	5.06	5.59	6.96	10.38	12.53	10.77
Accrued Expenses	4	5.46	5.64	8.09	10.55	8.62
Short-Term Debt	10.15	9.98	20.36	69.8	-	-
Current Portion of Leases	0.89	0.95	3.25	2.44	2.55	1.77
Unearned Revenue	1.13	0.97	1.13	0.78	0.87	0.68
Other Current Liabilities	-	-	-	8.53	9.38	-
Total Current Liabilities	21.23	22.94	37.34	100.03	35.88	21.84
Long-Term Leases	5.97	5.97	3.68	7.18	9.12	8.93
Other Long-Term Liabilities	0.14	0.25	0.27	11.04	13.1	9.21
Total Long-Term Liabilities	6.11	6.22	3.95	18.22	22.22	18.14
Total Liabilities	27.34	29.16	41.3	118.25	58.1	39.98
Common Stock	0	0	-	-	0	0.03
Additional Paid-in Capital	765.37	764.03	728.57	677.34	599.23	553.75
Accumulated Other Comprehensive Income	0.01	0.02	0.03	0.02	-1.12	-0.54
Retained Earnings	-727.92	-719.62	-693.23	-581.21	-348.72	-216.12
Shareholders' Equity	37.46	44.42	35.38	96.16	249.4	337.12
Total Liabilities & Equity	64.8	73.58	76.67	214.4	307.5	377.1
Total Debt	17.01	16.89	27.3	79.41	11.67	10.7
Net Cash (Debt)	-2.61	2.38	-17.82	-12.64	101.52	239.92
Net Cash Growth	-	-	-	-	-57.69%	984.42%
Net Cash Per Share	-0.00	0.44	-14.02	-22.22	210.61	520.08
Book Value	37.46	44.42	35.38	96.16	249.4	337.12
Book Value Per Share	0.02	8.16	27.83	168.99	517.40	730.79
Tangible Book Value	34.46	40.08	25.67	62.18	130.97	280.21
Tangible Book Value Per Share	0.02	7.36	20.20	109.28	271.70	607.43

SEC Filings: 10-K · 10-Q